The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kotrekhova L.P.

Sankt-Peterburg Academy of Post-Diploma Education;
P.N. Kashkin Research Institute of Medical Mycology

Vashkevich A.A.

GBOU VPO Severo-Zapadnyĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.I. Mechnikova Minzdrava Rossii, Sankt-Peterburg

Prevention of recurrent foot onychomycosis with 5% amorolfine lacquer in patients completing therapy with a full recovery

Authors:

Kotrekhova L.P., Vashkevich A.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2013;11(6): 86‑91

Read: 2226 times

Download PDF (RU)
Contact the author
Table of contents

PREVENTION OF RECURRENT FOOT ONYCHOMYCOSIS WITH 5% AMOROLFINE LACQUER IN PATIENTS COMPLETING THERAPY WITH A FULL RECOVERY
PREVENTION OF RECURRENT FOOT ONYCHOMYCOSIS WITH 5% AMOROLFINE LACQUER IN PATIENTS COMPLETING THERAPY WITH A FULL RECOVERY

To cite this article:

Kotrekhova LP, Vashkevich AA. Prevention of recurrent foot onychomycosis with 5% amorolfine lacquer in patients completing therapy with a full recovery. Russian Journal of Clinical Dermatology and Venereology. 2013;11(6):86‑91. (In Russ.)

 
Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Analysis of medi­cal preventive stru­ctures staff resources in 2023. Russian Journal of Preventive Medi­cine. 2024;(10):45-51
Proton pump inhi­bitors: posi­tive and nega­tive properties. On the 45th anni­versary of their discovery. Russian Journal of Preventive Medi­cine. 2024;(11):135-140
Study of opinions of medi­cal students on medi­cal prevention issues. Russian Journal of Preventive Medi­cine. 2024;(12):69-74
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Prevention of periodontal inflammation in microgravity mode­ling. Stomatology. 2024;(6-2):23-28
Effe­ctiveness of risk-guided cardiac mana­gement in patients with HER2-positive breast cancer and cancer therapy-related cardiac dysfunction. Russian Cardiology Bulletin. 2024;(4-2):144-153
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Vita­min D role in oral cavity diseases. Stomatology. 2025;(1):81-86
Abstract:

Keywords:

foot onychomycosis
prevention
amorolfine

Authors:

Kotrekhova L.P.

Sankt-Peterburg Academy of Post-Diploma Education;
P.N. Kashkin Research Institute of Medical Mycology

Vashkevich A.A.

GBOU VPO Severo-Zapadnyĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.I. Mechnikova Minzdrava Rossii, Sankt-Peterburg

Close metadata

References:

  1. Summerbell R.C. Epidemiology and ecology of onychomycosis. Dermatology 1997; 194: 32-36.
  2. Elewski B.E. Onychomycosis. Treatment, quality of life, and economic issue. Am J Clin Dermatol 2000; 1: 1: 19-26.
  3. Sergeev Yu.V., Sergeev A.Yu. Onikhomikozy; gribkovye infektsii nogtei. M: Geotar 1998; 40-41.
  4. Sigurgeirsson B., Olafsson J.H. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. J Eur Acad Dermatol Venerol 2010; 24: 8: 910-915.
  5. Lecha M. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain. Br J Dermatol 2001; 145: Suppl 60: 21-26.
  6. Baran R., Feuilhade M., Combernale P. et al. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol 2000; 142: 6: 1177-1183.
  7. Baran R., Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venerol 2005; 19: 21-29.
  8. Qiang Y.Z., Li X.J., Dan L. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. J Dermatol Treatment 2012; 23: 6: 449-452.
  9. Scher R.K., Baran R. Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol 2003; 149: Suppl 65: 5-9.
  10. Rukavishnikova V.M. Mikozy stop. M 1999.
  11. Potekaev N.S., Potekaev N.N., Rukavishnikova V.M. Lamizil: 10 let v Rossii. M 2003.
  12. Li R.Y., Wan Z., Wang A.P., Shen Y.N., Lu C.M., Li M., Xi L.Y., Liu W.D., Zeng F.Q. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China. Mycosis 2004; 47: 9-10: 402-406.
  13. Polak A., Jäckel A., Noack A., Kappe R. Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives. Mycoses 2004; 47: 5-6: 184-192.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.